Compared with the HFD group, we found that the mRNA expression levels of PPARα were significantly increased, whereas the gene expression levels of PPARγ were suppressed observably with MDG-1 intervention (Figure 6a), implying that MDG-1 could improve hyperlipidemia through regulating PPARs signaling. The gene discussed is PPARA; the disease is hyperlipidemia.